Preferred Drug List Requirements Sample Clauses

Preferred Drug List Requirements. The Contractor shall maintain a preferred drug list (PDL). In accordance with IC 12-15- 35-46, State approval of the PDL shall be required prior to Contractor implementation. The Contractor shall submit the proposed PDL to FSSA at least thirty-five (35) calendar days before the intended PDL implementation date. The FSSA shall submit the PDL to the DUR Board for review and recommendation. The Contractor shall be accessible to the DUR Board to respond to any questions regarding the PDL. The DUR Board will provide a recommendation regarding approval of the PDL in accordance with the terms of IC 00-00-00-00. FSSA will approve, disapprove or modify the formulary based on the DUR Board’s recommendation. The Contractor shall comply with the decision within sixty (60) days after receiving notice of the decision. The Contractor shall utilize a Pharmacy and Therapeutics Committee which shall meet regularly to make recommendations for changes to the PDL. In accordance with IC 00- 00-00-00, prior to removing one (1) or more drugs from the PDL or placing new restrictions on one (1) or more drugs, the Contractor shall submit the proposed change to FSSA which shall forward the proposal to the DUR Board. Such changes shall be submitted at least thirty-five (35) calendar days in advance of the proposed change. The Contractor shall also meet with FSSA staff and/or the DUR Board, as directed by FSSA, to answer questions about the clinical rationale for the proposed change. The Contractor is not required to seek approval from the State in order to add a drug to the PDL; however, the Contractor shall notify FSSA of any addition to the PDL within thirty (30) days after making the addition. The Contractor shall maintain an Over-the-Counter (OTC) Drug Formulary which contains, at a minimum, the same items included in the Hoosier Healthwise fee-for- service OTC Formulary and as updated by the DUR Board. Any additions to the Contractor OTC Drug Formulary are required to only be from participating rebating labelers. The PDL shall be made readily available to providers in the Contractor’s network and to members. The PDL shall be updated to reflect all changes in the status of a drug or addition of new drugs. The Contractor shall also support e-Prescribing technologies to communicate the PDL to prescribers through electronic medical records (EMRs) and e- Prescribing applications. Refer to 3.8.5 for additional requirements on e-Prescribing. Notwithstanding the foregoing, the Contractor...
Sample 1Sample 2Sample 3See All (10)
AutoNDA by SimpleDocs
Preferred Drug List Requirements. The Contractor shall maintain a preferred drug list (PDL). In accordance with IC 12-15- 35-46, State approval of the PDL shall be required prior to Contractor implementation. The Contractor shall submit the proposed PDL to FSSA at least thirty-five (35) calendar days before the intended PDL implementation date. The FSSA shall submit the PDL to the DUR Board for review and recommendation. The Contractor shall be accessible to the DUR Board to respond to any questions regarding the PDL. The DUR Board will provide a recommendation regarding approval of the PDL in accordance with the terms of IC 00-00-00-00. FSSA will approve, disapprove or modify the formulary based on the DUR Board’s recommendation. The Contractor shall comply with the decision within sixty
Sample 1Sample 2Sample 3See All (9)
Preferred Drug List Requirements. The Contractor shall maintain a preferred drug list (PDL). In accordance with IC 00-00-00-00, State approval of the PDL shall be required prior to Contractor implementation. The Contractor shall submit the proposed PDL to FSSA at least thirty-five (35) calendar days before the intended PDL implementation date. The FSSA shall submit the PDL to the DUR Board for review and recommendation. The Contractor shall be accessible to the DUR Board to respond to any questions regarding the PDL. The DUR Board will provide a recommendation regarding approval of the PDL in accordance with the terms of IC 12-15-35- 46. FSSA will approve, disapprove or modify the formulary based on the DUR Board’s recommendation. The Contractor shall comply with the decision within sixty (60) days after receiving notice of the decision. Per CFR 438.10(i)(1)-(2), the Contractor shall make available in electronic or paper form, the covered drug list(s) of medications including the reference brand and generic names of each drug as well as what tier each drug is on. The Contractor shall utilize a Pharmacy and Therapeutics Committee which shall meet regularly to make recommendations for changes to the PDL. In accordance with IC 12-15- 35-47, prior to removing one (1) or more drugs from the PDL or placing new restrictions on one (1) or more drugs, the Contractor shall submit the proposed change to FSSA which shall forward the proposal to the DUR Board. Such changes shall be submitted at least thirty-five
Sample 1Sample 2Sample 3
Preferred Drug List Requirements. The Contractor shall maintain a preferred drug list (PDL). In accordance with IC 00-00-00-00, State approval of the PDL shall be required prior to Contractor implementation. The Contractor shall submit the proposed PDL to OMPP at least thirty -five (35) calendar days before the intended PDL implementation date. OMPP shall submit the PDL to the DUR Board for review and recommendation. The Contractor shall be accessible to the DUR Board to respond to any questions regarding the PDL. The DUR Board will provide a recommendation regarding approval of the PDL in accordance with the terms of IC 12-15-35-
Sample 1Sample 2Sample 3
Preferred Drug List Requirements. The Contractor shall maintain a preferred drug list (PDL). In accordance with IC 12-15- 35-46, State approval of the PDL shall be required prior to Contractor implementation. The Contractor shall submit the proposed PDL to OMPP at least thirty -five (35) calendar days before the intended PDL implementation date. OMPP shall submit the PDL to the DUR Board for review and recommendation. The Contractor shall be accessible to the DUR Board to respond to any questions regarding the PDL. The DUR Board will provide a recommendation regarding approval of the PDL in accordance with the terms of IC 00- 00-00-00. OMPP will approve, disapprove, or modify the formulary based on the DUR Board’s recommendation. The Contractor shall comply with the decision within sixty (60) days after receiving notice of the decision. Per CFR 438.10(i)(1)-(2), the Contractor shall make available in electronic or paper form, the covered drug list(s) of medications including the reference brand and generic names of each drug as well as what tier each drug is on. EXHIBIT 1
Sample 1

Related to Preferred Drug List Requirements

  • Report Requirements The Company will send to the Reinsurer the following reports electronically, by the times indicated below:

  • CERTIFICATION REGARDING DRUG-FREE WORKPLACE REQUIREMENTS The undersigned (authorized official signing for the contracting organization) certifies that the contractor will, or will continue to, provide a drug-free workplace in accordance with 45 CFR Part 76 by:

  • Program Requirements A. The parties shall comply with the Disadvantaged Business Enterprise Program requirements established in 49 CFR Part 26.

  • Federal Medicaid System Security Requirements Compliance Party shall provide a security plan, risk assessment, and security controls review document within three months of the start date of this Agreement (and update it annually thereafter) in order to support audit compliance with 45 CFR 95.621 subpart F, ADP System Security Requirements and Review Process.

  • System Requirements Apple Software is supported only on Apple-branded hardware that meets specified system requirements as indicated by Apple.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!